First Implication The first implication is the most fundamental: any patient taking insulin, a sulfonylurea, or a meglitinide is at risk for hypoglycemia, and we must monitor for it actively throughout our sessions
Studies employing standardized measures to detect taste threshold largely support a post-surgical increase in sweet taste sensitivity, hence a reduced threshold for sweet taste [858687]
The more immediate and actionable concerns are often hydration, electrolytes, kidney function, blood sugar, gastrointestinal tolerance, gallbladder health, nutritional adequacy, and preservation of lean tissue
Two caveats temper the result: nausea occurred in 46% of lixisenatide-treated participants and vomiting in 13%, raising the possibility of functional unblinding, and the MDS-UPDRS is a clinical scale rather than a direct measure of dopaminergic neuron survival